MAPT and Alzheimer disease: While some studies report that suppressing microglial function reduces the pathological burden of AD-associated Aβ and tau [12–14], others have shown that early glial activation mediated by cytokines could have a beneficial effect in preventing or clearing protein aggregates [15–17].